Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Everolimus

Myelosuppression: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yi G-Z, et al. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization. BMC Neurology 22: 390, No. 1, 12 Oct 2022. Available from: URL: http://doi.org/10.1186/s12883-022-02920-x Yi G-Z, et al. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization. BMC Neurology 22: 390, No. 1, 12 Oct 2022. Available from: URL: http://​doi.​org/​10.​1186/​s12883-022-02920-x
Metadaten
Titel
Everolimus
Myelosuppression: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41444-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Minoxidil

Case report

Multiple drugs

Case report

Azd-1222

Case report

Multiple drugs